WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2010> 21

Volume: 21

1. Combined open surgical and endovascular management of ruptured femoral artery from recurrent vulvar cancer. Page:276—278
2. Sarcoma botryoides (embryonal rhabdomyosarcoma) of the uterine cervix in sisters. Page:273—275
3. Endometrial mullerian adenosarcoma after toremifene treatment in breast cancer patients: a case report. Page:269—272
4. The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells. Page:262—268
5. Apoptosis-related mRNA expression profiles of ovarian cancer cell lines following cisplatin treatment. Page:255—261
6. Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer. Page:248—254
7. Epidemiological characteristics of ovarian cancer in Korea. Page:241—247
8. Outcomes of advanced and recurrent cervical cancer treated with cisplatin and generic topotecan: retrospective analysis in a tertiary care hospital in Thailand. Page:237—240
9. The role of prophylactic cerclage in preventing preterm delivery after electrosurgical conization. Page:230—236
10. Pregnancy outcome after cervical conization: risk factors for preterm delivery and the efficacy of prophylactic cerclage. Page:225—229
11. In reply: A large-scale study on the role of ovarian symptom index is necessary. Page:66—66
12. A hospital-based case-control study of identifying ovarian cancer using symptom index. Page:65—65
13. Lipoleiomyoma of broad ligament mimicking ovarian cancer in a postmenopausal patient: case report and literature review. Page:62—64
14. Metastasis to the ovaries from transitional cell carcinoma of the bladder and renal pelvis: a report of two cases. Page:59—61
15. Cellular fibroma of the ovary containing Leydig cell hyperplasia: a case report. Page:56—58
16. The expression of syndecan-1 is related to the risk of endometrial hyperplasia progressing to endometrial carcinoma. Page:50—55
17. Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implications for endometrial cancer treatment. Page:45—49
18. Proliferation of CD4(+)CD25(high+)Foxp3(+) regulatory T lymphocytes in ex vivo expanded ascitic fluid from primary and recurrent ovarian carcinoma. Page:38—44
19. Expression pattern of the class I homeobox genes in ovarian carcinoma. Page:29—37
20. Obesity does not affect the number of retrieved lymph nodes and the rate of intraoperative complications in gynecologic cancers. Page:24—28
21. Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy. Page:18—23
22. Use of transrectal ultrasound for high dose rate interstitial brachytherapy for patients of carcinoma of uterine cervix. Page:12—17
23. Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies. Page:3—11
24. Global cooperation in gynecologic cancer. Page:1—2
25. Erratum: Global cooperation in gynecologic cancer. Page:134—134
26. In reply: Tumor-associated lymphocytes expanded ex vivo from malignant ascites. Page:133—133
27. Proliferation of CD4(+)CD25(high+)Foxp3(+) regulatory T lymphocytes in ex vivo expanded ascitic fluid from primary and recurrent ovarian carcinoma. Page:132—132
28. Growing teratoma syndrome in a post laparoscopic excision of ovarian immature teratoma. Page:129—131
29. Mullerian adenosarcoma (heterologous) of the cervix with sarcomatous overgrowth: a case report with review of literature. Page:125—128
30. Follicular stimulating hormone enhances Notch 1 expression in SK-OV-3 ovarian cancer cells. Page:119—124
31. Wine drinking and epithelial ovarian cancer risk: a meta-analysis. Page:112—118
32. Comparison of laparoscopic versus conventional open surgical staging procedure for endometrial cancer. Page:106—111
33. The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women. Page:102—105
34. Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia. Page:97—101
35. The twenty-first century role of Piver-Rutledge type III radical hysterectomy and FIGO stage IA, IB1, and IB2 cervical cancer in the era of robotic surgery: a personal perspective. Page:219—224
36. Major clinical research advances in gynecologic cancer in 2010. Page:209—218
37. Prediction and prevention of preterm birth after cervical conization. Page:207—208
38. Co-occurrence of an adenoma malignum and an endocervical-type adenocarcinoma of the uterine cervix in a woman with Peutz-Jeghers syndrome. Page:203—206
39. Primary amelanotic melanoma of the cervix: case report with review of literature. Page:199—202
40. Skeletal muscle metastasis from carcinoma cervix: a case report. Page:196—198
41. Uterine metastases in ovarian carcinoma: frequency and survival in women who underwent hysterectomy. Page:191—195
42. The type of metastasis is a prognostic factor in disseminated cervical cancer. Page:186—190
43. High expression of mTOR is associated with radiation resistance in cervical cancer. Page:181—185
44. Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia. Page:174—180
45. GST (GSTM1, GSTT1, and GSTP1) polymorphisms in the genetic susceptibility of Turkish patients to cervical cancer. Page:169—173
46. Survival benefit of laparoscopic surgical staging-guided radiation therapy in locally advanced cervical cancer. Page:163—168
47. Current status in the management of uterine corpus cancer in Korea. Page:151—162
48. Asian society of gynecologic oncology workshop 2010. Page:137—150
49. Overview on the 1st International Workshop on Gynecologic Oncology. Page:135—136
50. Carboplatin and paclitaxel as an initial treatment in patients with stage IVb cervical cancer: a report of 7 cases and a review of the literature. Page:93—96
51. Absence of dysplasia in the excised cervix by a loop electrosurgical excision procedure in the treatment of cervical intraepithelial neoplasia. Page:87—92
52. Identifying barriers to Papanicolaou smear screening in Korean women: Korean National Health and Nutrition Examination Survey 2005. Page:81—86
53. Maximal cytoreductive effort in epithelial ovarian cancer surgery. Page:75—80
54. Evolving strategies for ovarian cancer: gynecologic oncology in ASCO's 46th annual meeting. Page:72—74
55. Towards eradication of cervical cancer: 4th biennial conference of the Asia Oceania research organization on Genital Infections & Neoplasia (AOGIN). Page:70—71
56. Laparoscopic surgery is a current tide of widely accepted standard procedure for endometrial cancer. Page:67—69